Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|February 13, 2023
The Post-insertion Method for the Preparation of PEGylated LiposomesSherif E Emam, Nehal E Elsadek, Taro Shimizu, et al.Journal of Pharmaceutical Sciences|June 24, 2025
Using PEGylated antigen-expressing extracellular vesicles to accomplish splenic B cell-targeted antigen delivery for induction of antibodies against SARS-CoV-2 spike proteinSherif E Emam, Nehal E Elsadek, Haruka Takata, et al.International Journal of Pharmaceutics|March 30, 2021
Nucleic acids delivered by PEGylated cationic liposomes in systemic lupus erythematosus-prone mice: A possible exacerbation of lupus nephritis in the presence of pre-existing anti-nucleic acid antibodiesHaruka Takata, Taro Shimizu, Yoshino Kawaguchi, et al.Biological & Pharmaceutical Bulletin|September 4, 2020
Pegfilgrastim (PEG-G-CSF) Induces Anti-polyethylene Glycol (PEG) IgM via a T Cell-Dependent MechanismNehal E Elsadek, Sherif E Emam, Amr S Abu Lila, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 24, 2023
Anti-PEG IgM production induced by PEGylated liposomes as a function of administration routeHaruka Takata, Taro Shimizu, Rina Yamade, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 8, 2020
Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in miceNehal E Elsadek, Amr S Abu Lila, Sherif E Emam, et al.Materials (Basel, Switzerland)|March 10, 2022
Electrospun Nanofibers Revisited: An Update on the Emerging Applications in NanomedicineNehal E Elsadek, Abdalrazeq Nagah, Tarek M Ibrahim, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 6, 2021
Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in miceSherif E Emam, Nehal E Elsadek, Amr S Abu Lila, et al.Molecular Pharmaceutics|June 11, 2020
Impact of Pre-Existing or Induced Anti-PEG IgM on the Pharmacokinetics of Peginterferon Alfa-2a (Pegasys) in MiceNehal E Elsadek, Eri Hondo, Taro Shimizu, et al.Biological & Pharmaceutical Bulletin|January 4, 2022
Using Bio-Layer Interferometry to Evaluate Anti-PEG Antibody-Mediated Complement ActivationMahmoud Mostafa, Nehal E Elsadek, Sherif E Emam, et al.Pageof 2